Views & Analysis | Perspectives on pharma industry issues

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

R&D

Cardiovascular disease today: NMR-based lipoprotein profilin...

pharmaphorum spoke with Andreas Wolf, chief technology officer at numares Health about NMR-based lipoprotein profiling and cardiovascular disease.

Articles

A new look at patient communications in outcomes-driven heal...

Susan Carr addresses the importance of effectively communicating patient self-management techniques in tackling patient adherence and the role that digital can play in this communication. Around the world, healthcare markets are changing rapidly as patients, healthcare providers and payers demand lower costs, higher quality...

Articles

Challenges to personalised medicine

As our personalised medicine theme comes to an end, Duncan McHale, Vice President of Global Exploratory Development at UCB, shares his thoughts on personalised medicine. Duncan McHale has a long history in personalised medicines. He helped to set up the pharmacogenomics programme at Pfizer...

Articles

Editor’s Voice: October – time to get personal

As we’re sure you’ve been aware, October has been our personalised medicine focus month. Find out what we loved this month and take a look at what’s to come for the rest of 2012. I suppose I should start by saying…. “Happy Halloween”!! While there were no ghosts or goblins on pharmaphorum…

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital